WuXi Biologics falls on US security risk concerns

WuXi Biologics (Cayman)

17/05/2024 09:09

** Shares of WuXi Biologics  2269.HK  fall 3.4% to HK$14.06
    ** Co says it noted that a meeting in relation to a revised
version of a draft bill was held by the U.S. House Committee on
Oversight and Accountability on May 15
        ** Says the bill includes co in the proposed definition
of the term “biotechnology company of concern”, which it
believes is a preemptive and unjustified designation
  
    ** Co says it does not have a human genomics business nor
does it collect human genomic data in any of its businesses
    ** Adds it does not and will not pose a security risk to the
United States or any other countries
    ** Hong Kong shares of WuXi AppTec  2359.HK  slip 1.6% and
Shanghai stock  603259.SS  eases 1.5%
    ** WuXi Biologics is down 52.4% YTD

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))